HCPLive Network

Extended Sleep Time Linked to Reduced Pain Sensitivity

 
WEDNESDAY, Dec. 5 (HealthDay News) -- Extending bedtime for sleepy healthy adults reduces daytime sleepiness and correlates with reduced pain sensitivity, according to a study published in the Dec. 1 issue of SLEEP.

Timothy A. Roehrs, Ph.D., of the Sleep Disorders and Research Center at the Henry Ford Hospital in Detroit, and colleagues conducted a study involving 18 health volunteers who had an average daily sleep latency of less than 8 minutes on the multiple sleep latency test (MSLT). Participants were randomized to four nights of extended sleep (10 hours per night) or four nights of their regular bedtime. Daytime sleepiness was measured on days one and four using the MSLT, and pain sensitivity was assessed using finger withdrawal latency pain testing to a radiant heat stimulus.

The researchers found that those in the extended sleep group slept an average of 1.8 hours more per night compared with those who continued their usual regular bedtime, and their average daily sleep latency increased on the MSLT. In the extended sleep group, finger withdrawal latency was also increased, indicative of a reduction in pain sensitivity. During the four experimental nights, the increase in sleep time correlated with improvement on the MSLT, which was associated with decreased sensitivity to pain.

"The current results suggest that the increased pain sensitivity of the sleepy individuals is the result of their underlying sleepiness, which the results of this study show is a state and not a trait phenomenon," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2012 HealthDay. All rights reserved.
 
 

Further Reading
Researchers have developed a math model that can accurately predict the progression from nephritis to interstitial fibrosis in patients with systemic lupus erythematosus.
Recent studies looking at neural response in patients with fibromyalgia have shown that people with this condition may have hypersensitivity to non-painful stimuli.
Adverse drug events involving psychiatric medications are not uncommon in emergency departments, according to a study published in JAMA Psychiatry.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) reported that proactive monitoring of dose adjustments of infliximab (IFX), one of the 4 anti-TNF-alpha proteins used to treat inflammatory diseases like Crohn’s disease (CD), ulcerative colitis (UC), and inflammatory bowel disease (IBD), could prolong the effectiveness of treatment.
The number of Americans dying from accidental overdoses of opioid analgesics jumped significantly from 1999 to 2011, according to a September data brief published by the US Centers for Disease Control and Prevention's National Center for Health Statistics.
About 14.5 million US cancer survivors are alive today, compared to just three million in 1971, the American Association for Cancer Research reported Tuesday.
The outbreak of the Ebola virus in West Africa is showing no signs of slowing down. As a result, President Barack Obama announced Tuesday that the United States would be getting even more directly involved in the effort to contain the outbreak and prevent it from spreading any further.
More Reading